A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia.

[Stephane P. Rousseau (RCU)]

A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia.

Touch S, Suraratdecha C, Samnang C, Heng S, Gazley L, Huch C, Sovann L, Chhay CS, Soeung SC.

Communicable Disease Control Department, Ministry of Health, Cambodia.

Abstract

This study aimed to evaluate the cost and effectiveness of introducing a live, attenuated vaccine (SA 14-14-2) against Japanese encephalitis (JE) into the immunization program. The study demonstrated that SA 14-14-2 immunization is cost-effective in controlling JE in Cambodia compared to no vaccination. Averting one disability-adjusted life year, from a societal perspective, through the introduction of SA 14-14-2 through routine immunization, or a combination of routine immunization plus a campaign targeting children <5 or <10 years of age, costs US$22, US$34 and US$53, respectively. Sensitivity analyses confirmed that there was a high probability of SA 14-14-2 immunization being cost-effective under conditions of uncertainty. Copyright © 2010. Published by Elsevier Ltd.

http://www.ncbi.nlm.nih.gov/pubmed/20470803

______________________
Stéphane P. Rousseau (Mr)
Regional Coordinator

Regional Coordination Unit (RCU)
Asian Development Bank
Greater Mekong Subregion
Communicable Diseases Control Project
Room 2104, 21st Floor,
Thanh Cong Tower,
57 Lang Ha Street,
Ba Dinh District, Hanoi – VIET NAM
Tel: +844 3514 79 33
Fax: +844 3514 80 12
Email: gms.c...@gmail.com
Website: www.gms-cdc.org/
Skype: rcu_gms_cdc